Journals / Türk Anestezi ve Reanimasyon Dergisi / 2005 / Cilt: 33 - Sayı: 5

Treatment of severe thrombocytopenia and edema by antivenin therapy in vipera lebetina snake bites (Two case reports)

Koca Engerek (Kör Yılan) ısırılması sonrası gelişen ciddi trombositopeni ve ödemin yılan antiserumu ile tedavisi

Pages
424–428
Publication Date
2022-11-04
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

It is recommended that extra antivenin doses should be administered when thrombocytopenia and progressive swelling occur in Vipera Lebetina snake bites.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Vipera Lebetina (big viper-blind snake) is the longest, thickest and most venomous snake in Turkey.
📊
Key Findings & Data:Severe thrombocytopenia, edema, ecchymosis and precompartment syndrome were developed in both patients within 48-72 hours.
💡
Conclusion & Impact:It is recommended that extra antivenin doses should be administered when thrombocytopenia and progressive swelling occur in Vipera Lebetina snake bites.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Vipera Lebetina (big viper-blind snake) is the longest, thickest and most venomous snake in Turkey. Specific antivenin is indicated for both systemic effects and marked progressive local signs. In the snake envenomations, supportive care was given after single dose of intramuscular antivenin. Two patients suffered from snake bites were hospitalized with light edema and pain. Severe thrombocytopenia, edema, ecchymosis and precompartment syndrome were developed in both patients within 48-72 hours. Thrombocytopenia did not respond to thrombocyte transfusions. Clinical and laboratory findings were recovered dramatically after additional intravenous antivenin therapy. It is recommended that extra antivenin doses should be administered when thrombocytopenia and progressive swelling occur in Vipera Lebetina snake bites.

Özet

Vipera Lebetina (koca engerek-kör yılan), Türkiye'de yaşayan en uzun, en kalın ve en zehirli yılan türüdür. Zehirinin sistemik ve lokal etkilerini önlemek için özgün yılan antiserumu kullanılmaktadır. Bu tip zehirlenmelerde, tek doz yılan antiserumunun kas içine uygulanması sonrasında destekleyici tedavi de uygulanmaktadır. Sözü edilen yılan türüyle zehirlenen 2 olgu, hafif ödem ve ağrı yakınmaları ile yoğun bakım ünitemizde takip edilirken, hastalarda 48-72 saat içinde, ciddi trombositopeni, ödem, ekimoz ve prekompartman sendromu gelişti. Trombosit transfüzyonlarına rağmen trombositopeni düzeltilemedi. Damar içine uygulanan ek yılan antiserum infüzyonları klinik durum ve laboratuvar bulgularını hızlıca düzeltti.Koca engerek türü yılan sokmalarında, gelişen trombositopeni ve ödemin tedavisi amacıyla ilave yılan antiserumları kullanılmalıdır.

🔖

Cite This Article

SARBAN, S., CENGİZ, M., GANİDAĞLI, S. (2022). Treatment of severe thrombocytopenia and edema by antivenin therapy in vipera lebetina snake bites (Two case reports). Türk Anestezi ve Reanimasyon Dergisi, Cilt: 33 - Sayı: 5, 424–428. https://ajindex.com/articles/620156

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Buncher L. (2005). Macrovipera Lebetina. The web site http://www.serpentes.ch/central/deu/Schlangenbilder/andere/detail/Macrovipera_ lebetina_004.htm
  2. TÜBİTAK. (2004). Türkiye tür listeleri, Vipera lebetina (Linnaeus, 1758) Koca Engerek. The web site:
  3. Ellenhorn M, Schonwald S, Ordog G, et al. Envenomations-bites and stings. In: Ellenhorn's Medical Toxycology. 2 nd edition. Baltimore: Williams & Wilkins; 1997,1737-1798
  4. Seddik SS, Wanas S, Helmy MH, et al. Cross neutralization of dangerous snake venoms from Africa and the Middle East using the VACSERA polyvalent antivenom. Egyptian Organization for Biological Products & Vaccines. J Nat Toxins 2002; 11:329-335
  5. Bentur Y, Cahana A. Unusual local complications of Vipera palaestinae bite. Toxicon 2003; 41:633-635
  6. Bentur Y, Raikhlin-Eisenkraft B, Galperin M. Evaluation of antivenom therapy in Vipera palaestinae bites Toxicon 2004; 44:53-57
  7. Shemesh IY, Kristal C, Langerman L, et al. Preliminary evaluation of Vipera palaestinae snake bite treatment in accordance to the severity of the clinical syndrome. Toxicon 1998; 36:867-873
  8. Kaygusuz S, Aydın K, Çaylan R, et al. Kliniğimizde izlediğimiz yılan sokması olgularının değerlendirilmesi. Türkiye Tıp Derg. Dahili Tıp Bilimleri. 2001; 8:116-121
  9. Keleş G, Toprak V, Yentür A, et al. Yılan zehirlenmesi ve kompartman sendromu (iki olgu nedeniyle). Anestezi Derg 2003; 11:298-301
  10. Söker M, Haspolat K. Türkiye'nin Güneydoğu Anadolu Bölgesinde çocuklarda yılan ısırması: 52 vaka nedeniyle. Gülhane Tıp Derg 1999; 41:331-337
  11. Baran İ. Türkiye yılanlarının taksonomik revizyonu ve coğrafi dağılışları: TÜBİTAK, 1976
  12. İsmail M, Memish Z. Venomous snakes of Saudi Arabia and the Middle East: a keynote for travellers. Int J Antimicrob Agents 2003; 21:164-169
  13. WHO. Bites and stings due to terrestrial and aquatic animals in Europe. Wkly Epidemiol Rec 2001; 76:290-298
  14. Rojnuckarin P, Mahasandana S, Intragumthorn- chai T, et al. Prognostic factors of green pit viper bites. Am J Trop Med Hyg 1998; 58:22-25
  15. Fatehi-Hassanabad Z, Fatehi M. Characterisation of some pharmacological effects of the venom from Vipera lebetina. Toxicon 2004; 43:385-391
  16. Segev G, Shipov A, Klement E, et al. Vipera palaestinae envenomation in 327 dogs: a retrospective cohort study and analysis of risk factors for mortality. Toxicon 2004; 43:691-699.